← European Medicine Shortage Tracker · all medicines

Myocet liposomal shortage — availability across Europe

Myocet liposomal currently has availability issues reported in 1 European register: Spain.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: MYOCET LIPOSOMAL · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Myocet liposomal has active availability issues in 1 of 10 tracked European registers.
Registers reporting issues: Spain.
Latest expected-resolution date on file: 2026-08-13.
Data source: 1 official medicines-agency register, refreshed daily.

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Myocet liposomal, covering 1 affected product presentation. Where agencies state a cause, distribution or shipping problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-08-13; the earliest is 2026-08-13.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇪🇸 Spain	Shortage MYOCET LIPOSOMAL 50 MG POLVO, DISPERSION Y DISOLVENTE PARA CONCENTRADO PARA DISPERSION PARA PERFUSION 2 kits (kit compuesto por 1 vial de 50 mg + 1 vial de liposomas + 1 vial de	2026-07-30	2026-08-13	Distribución controlada por el titular.	register ↗

Full report history (1 register entry)

Every individual register entry for Myocet liposomal in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇪🇸 ES	MYOCET LIPOSOMAL 50 MG POLVO, DISPERSION Y DISOLVENTE PARA CONCENTRADO	Shortage	2026-07-30	2026-08-13	Distribución controlada por el titular.

Frequently asked

Is Myocet liposomal currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Spain. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Myocet liposomal shortage expected to end?

Agency prognoses on file range from 2026-08-13 to 2026-08-13. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Where does this Myocet liposomal availability data come from?

Directly from the official medicines-agency register that lists Myocet liposomal: AEMPS CIMA (Spain). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Myocet liposomal — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/myocet-liposomal/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Myocet liposomal availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/myocet-liposomal/">Myocet liposomal shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Myocet liposomal: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.